RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-induced psychosis
Accession: DOID:8646
browse the term
Definition: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Synonyms: exact_synonym: Drug Psychoses; Toxic Psychoses; substance-induced psychoses
primary_id: MESH:D011605 ; RDO:0006434
xref: ICD9CM:293.89
For additional species annotation, visit the
Alliance of Genome Resources .
Please select species to view GViewer data.
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chrNW_004624849:998,262...1,019,305
Ensembl chrNW_004624849:998,277...1,019,521
G
P
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
D
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
B
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
R
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
M
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
H
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
N
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chrNW_004624747:9,846,254...9,860,938
Ensembl chrNW_004624747:9,851,153...9,860,094
G
G
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
G
P
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
G
S
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chrNW_004936619:597,970...618,564
Ensembl chrNW_004936619:608,441...616,779
G
D
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr26:28,141,076...28,150,600
Ensembl chr26:28,141,076...28,150,598
G
B
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr22:5,233,876...5,248,622
Ensembl chr22:22,104,253...22,114,189
G
C
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chrNW_004955455:7,886,720...7,906,214
Ensembl chrNW_004955455:7,895,974...7,906,505
G
R
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,853...13,333,386
G
M
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
H
ADORA2A
adenosine A2a receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
N
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
G
G
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
P
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
G
S
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
G
D
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
B
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
C
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
R
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
M
Akt1
thymoma viral proto-oncogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
H
AKT1
AKT serine/threonine kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
N
Camk2b
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chrNW_004624740:7,750,327...7,828,891
Ensembl chrNW_004624740:7,750,245...7,831,454
G
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr21:14,342,751...14,451,274
Ensembl chr21:14,342,892...14,451,282
G
P
CAMK2B
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr18:50,862,225...50,956,263
Ensembl chr18:50,861,466...50,956,225
G
S
Camk2b
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chrNW_004936478:19,183,493...19,278,457
Ensembl chrNW_004936478:19,180,726...19,278,920
G
D
CAMK2B
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
G
B
CAMK2B
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr 7:44,930,859...45,040,078
Ensembl chr 7:45,001,267...45,110,342
G
C
Camk2b
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chrNW_004955456:7,711,583...7,760,506
Ensembl chrNW_004955456:7,713,552...7,760,207
G
R
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
M
Camk2b
calcium/calmodulin-dependent protein kinase II, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362
G
H
CAMK2B
calcium/calmodulin dependent protein kinase II beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
N
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chrNW_004624785:6,164,507...6,601,302
Ensembl chrNW_004624785:6,164,379...6,601,326
G
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr13:79,153,418...79,554,552
Ensembl chr13:79,270,265...79,554,549
G
P
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
S
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chrNW_004936489:4,616,839...4,887,179
Ensembl chrNW_004936489:4,614,754...4,887,171
G
D
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
B
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 6:149,507,599...149,918,523
Ensembl chr 6:154,317,002...154,631,551
G
C
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chrNW_004955439:9,588,631...9,953,606
Ensembl chrNW_004955439:9,588,201...9,963,353
G
R
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
M
Esr1
estrogen receptor 1 (alpha)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
H
ESR1
estrogen receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
N
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chrNW_004624730:5,419,892...5,431,268
Ensembl chrNW_004624730:5,419,896...5,431,361
G
G
GRM2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr22:13,044,974...13,056,469
Ensembl chr22:13,046,641...13,056,453
G
P
GRM2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr13:33,924,303...33,938,279
Ensembl chr13:33,926,804...33,938,269
G
S
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chrNW_004936529:3,042,220...3,053,670
Ensembl chrNW_004936529:3,042,248...3,053,673
G
D
GRM2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr20:37,915,178...37,926,276
Ensembl chr20:37,915,665...37,924,296
G
B
GRM2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 3:51,639,792...51,652,779
Ensembl chr 3:52,873,144...52,884,395
G
C
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chrNW_004955532:3,309,034...3,320,954
Ensembl chrNW_004955532:3,309,028...3,320,966
G
R
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
M
Grm2
glutamate receptor, metabotropic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 9:106,521,733...106,533,308
Ensembl chr 9:106,520,294...106,533,281
G
H
GRM2
glutamate metabotropic receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 3:51,707,068...51,718,613
Ensembl chr 3:51,707,068...51,718,613
G
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr 1:6,676,897...6,679,936
G
S
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
G
D
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
G
B
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
C
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
R
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
M
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
H
GSTP1
glutathione S-transferase pi 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
N
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chrNW_004624815:5,817,196...5,821,197
Ensembl chrNW_004624815:5,816,601...5,820,864
G
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 4:60,159,542...60,162,947
Ensembl chr 4:60,159,944...60,161,212
G
P
HTR1A
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr16:42,479,812...42,484,365
Ensembl chr16:42,478,923...42,484,304
G
S
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chrNW_004936480:5,042,531...5,047,157
Ensembl chrNW_004936480:5,043,204...5,044,472
G
D
HTR1A
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 2:50,005,277...50,006,548
Ensembl chr 2:50,002,740...50,006,548
G
B
HTR1A
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 5:50,045,266...50,049,636
Ensembl chr 5:51,692,416...51,693,684
G
C
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chrNW_004955446:4,913,181...4,917,726
Ensembl chrNW_004955446:4,913,884...4,915,146
G
R
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
M
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
H
HTR1A
5-hydroxytryptamine receptor 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
N
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chrNW_004624764:4,778,563...4,791,505
Ensembl chrNW_004624764:4,778,657...4,791,458
G
G
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr20:112,873,132...112,887,533
Ensembl chr20:112,874,734...112,887,066
G
P
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 6:78,077,358...78,092,211
G
S
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chrNW_004936474:5,848,719...5,858,520
Ensembl chrNW_004936474:5,848,707...5,859,749
G
D
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 2:79,022,790...79,033,975
Ensembl chr 2:79,022,775...79,033,975
G
B
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 1:18,619,683...18,635,822
Ensembl chr 1:19,662,978...19,678,680
G
C
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chrNW_004955452:323,641...338,312
G
R
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:151,296,662...151,311,912
G
M
Htr6
5-hydroxytryptamine (serotonin) receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 4:138,787,017...138,802,881
Ensembl chr 4:138,788,419...138,802,881
G
H
HTR6
5-hydroxytryptamine receptor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 1:19,664,875...19,680,966
Ensembl chr 1:19,664,875...19,680,966
G
P
LOC100739508
glutathione S-transferase P-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr 2:5,005,498...5,009,247
G
S
LOC101968921
angiotensin-converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
G
N
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chrNW_004624758:13,542,467...13,545,106
Ensembl chrNW_004624758:13,536,493...13,545,599
G
G
NPY1R
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 7:109,774,700...109,794,543
Ensembl chr 7:109,774,918...109,776,905
G
P
NPY1R
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 8:52,152,649...52,163,080
Ensembl chr 8:52,152,646...52,162,328
G
S
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chrNW_004936555:2,267,727...2,276,673
Ensembl chrNW_004936555:2,267,669...2,276,778
G
D
NPY1R
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr15:59,580,546...59,587,753
Ensembl chr15:59,580,809...59,583,237
G
B
NPY1R
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 4:155,583,870...155,604,336
Ensembl chr 4:167,372,310...167,381,597
G
C
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chrNW_004955403:41,681,834...41,693,094
Ensembl chrNW_004955403:41,681,728...41,694,020
G
R
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
M
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
G
H
NPY1R
neuropeptide Y receptor Y1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
N
Oprm1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chrNW_004624785:4,147,079...4,195,712
Ensembl chrNW_004624785:4,032,689...4,196,186
G
G
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr13:81,568,295...81,650,005
Ensembl chr13:81,568,732...81,625,088
G
P
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 1:12,634,125...12,702,295
Ensembl chr 1:12,528,672...12,702,443
G
S
Oprm1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
G
D
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 1:43,972,915...44,037,477
Ensembl chr 1:43,972,219...44,141,238
G
B
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 6:151,827,323...151,937,658
Ensembl chr 6:156,517,661...157,088,251
G
C
Oprm1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chrNW_004955439:7,870,563...7,923,817
Ensembl chrNW_004955439:7,757,569...7,923,817
G
R
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
M
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
H
OPRM1
opioid receptor mu 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
N
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chrNW_004624795:5,556,728...5,565,969
Ensembl chrNW_004624795:5,556,450...5,565,988
G
G
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr16:69,805,968...69,816,792
Ensembl chr16:69,806,923...69,816,754
G
P
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr12:25,596,520...25,609,693
Ensembl chr12:25,596,523...25,609,706
G
S
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chrNW_004936490:12,127,065...12,138,870
Ensembl chrNW_004936490:12,127,065...12,138,870
G
D
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr 9:25,525,711...25,536,722
Ensembl chr 9:25,526,649...25,536,722
G
B
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr17:8,189,555...8,200,491
Ensembl chr17:8,175,968...8,186,790
G
C
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chrNW_004955451:12,110,290...12,119,870
Ensembl chrNW_004955451:12,110,290...12,120,124
G
R
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:80,605,251...80,618,042
G
M
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
H
PHB1
prohibitin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,049...49,414,905
G
N
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chrNW_004624752:9,880,773...9,895,270
Ensembl chrNW_004624752:9,880,670...9,895,230
G
G
PICK1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr19:20,758,199...20,778,210
Ensembl chr19:20,759,960...20,779,514
G
P
PICK1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr 5:9,808,444...9,829,677
Ensembl chr 5:9,808,451...9,825,539
G
S
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chrNW_004936492:3,098,196...3,115,921
Ensembl chrNW_004936492:3,097,629...3,116,526
G
D
PICK1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr10:26,595,301...26,614,170
Ensembl chr10:26,595,768...26,613,756
G
B
PICK1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
Ensembl chr22:36,796,015...36,814,469
G
C
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chrNW_004955413:24,383,130...24,399,092
Ensembl chrNW_004955413:24,383,130...24,399,196
G
R
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:110,797,117...110,816,848
G
M
Pick1
protein interacting with C kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr15:79,113,373...79,133,666
Ensembl chr15:79,113,373...79,133,684
G
H
PICK1
protein interacting with PRKCA 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr22:38,057,255...38,075,701
Ensembl chr22:38,056,311...38,075,701
G
N
Rgs9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chrNW_004624870:3,138,311...3,249,297
Ensembl chrNW_004624870:3,143,950...3,218,117
G
G
RGS9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr16:56,199,051...56,291,002
Ensembl chr16:56,199,343...56,288,290
G
P
RGS9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr12:12,015,321...12,087,982
Ensembl chr12:12,015,321...12,087,976
G
S
Rgs9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chrNW_004936541:7,472,195...7,525,220
Ensembl chrNW_004936541:7,458,539...7,525,220
G
D
RGS9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr 9:14,809,977...14,905,299
Ensembl chr 9:14,809,864...14,905,197
G
B
RGS9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr17:59,085,707...59,176,368
Ensembl chr17:64,262,585...64,389,559
G
C
Rgs9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chrNW_004955478:4,614,730...4,683,152
Ensembl chrNW_004955478:4,614,701...4,683,167
G
R
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr10:94,696,556...94,770,387
Ensembl chr10:94,197,054...94,270,892
G
M
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr11:109,116,174...109,189,013
Ensembl chr11:109,116,181...109,188,955
G
H
RGS9
regulator of G protein signaling 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr17:65,137,370...65,227,703
Ensembl chr17:65,100,812...65,227,703
G
N
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chrNW_004624751:694,165...720,287
Ensembl chrNW_004624751:694,099...719,465
G
G
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 4:1,209,013...1,258,797
Ensembl chr 4:1,209,019...1,258,866
G
P
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr16:79,186,114...79,220,302
Ensembl chr16:79,186,108...79,220,297
G
S
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
G
D
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr34:11,209,118...11,245,456
Ensembl chr34:11,210,939...11,246,742
G
B
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
Ensembl chr 5:1,437,567...1,488,829
G
C
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chrNW_004955504:721,470...747,553
Ensembl chrNW_004955504:721,429...747,630
G
R
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
M
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
H
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
N
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chrNW_004624757:17,393,046...17,528,783
Ensembl chrNW_004624757:17,392,998...17,528,320
G
G
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 7:38,083,154...38,194,068
Ensembl chr 7:38,081,509...38,191,479
G
P
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 8:129,247,724...129,388,307
Ensembl chr 8:129,248,819...129,271,128
G
S
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chrNW_004936685:2,077,017...2,175,298
Ensembl chrNW_004936685:2,076,651...2,175,338
G
D
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr32:12,915,871...13,079,338
Ensembl chr32:12,916,215...13,060,383
G
B
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:82,018,585...82,132,938
Ensembl chr 4:92,737,608...92,850,600
G
C
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chrNW_004955405:854,011...962,741
Ensembl chrNW_004955405:853,946...965,403
G
R
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
M
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
H
SNCA
synuclein alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
N
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
G
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
P
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
S
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
G
D
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
B
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
C
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
R
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
M
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
H
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chrNW_004624747:20,407,190...20,438,605
Ensembl chrNW_004624747:20,403,717...20,438,690
G
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr11:107,019,015...107,060,784
Ensembl chr11:107,019,111...107,060,374
G
P
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr14:39,902,317...39,933,113
Ensembl chr14:39,896,565...39,933,124
G
S
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
G
D
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr26:9,319,109...9,361,021
G
B
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:109,343,020...109,385,060
Ensembl chr12:112,734,243...112,776,471
G
C
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
G
R
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
M
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
H
ALDH2
aldehyde dehydrogenase 2 family member
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
N
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004624784:8,810,409...8,821,732
Ensembl chrNW_004624784:8,810,559...8,820,444
G
G
ANKK1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 1:104,752,023...104,765,071
G
S
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004936612:1,161,961...1,173,318
G
D
ANKK1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 5:19,801,511...19,814,359
Ensembl chr 5:19,801,542...19,814,481
G
B
ANKK1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:108,267,717...108,280,635
Ensembl chr11:112,111,003...112,123,382
G
C
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004955412:15,036,071...15,046,118
Ensembl chrNW_004955412:15,035,388...15,046,139
G
R
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 8:49,779,862...49,788,024
Ensembl chr 8:49,779,862...49,788,024
G
M
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
H
ANKK1
ankyrin repeat and kinase domain containing 1
IAGP
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,387,779...113,400,416
Ensembl chr11:113,387,779...113,400,416
G
N
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
G
DRD2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
P
DRD2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
S
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
G
D
DRD2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
B
DRD2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
C
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
G
R
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
M
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
H
DRD2
dopamine receptor D2
IAGP
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
N
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chrNW_004624903:1,390,899...1,399,745
Ensembl chrNW_004624903:1,391,910...1,399,949
G
G
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:60,893,711...60,901,134
Ensembl chr X:60,893,526...60,902,844
G
P
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:57,132,549...57,140,377
Ensembl chr X:57,132,548...57,140,356
G
S
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chrNW_004936762:495,271...501,278
Ensembl chrNW_004936762:493,910...501,531
G
D
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:55,469,738...55,477,699
Ensembl chr X:55,469,382...55,477,699
G
B
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:60,364,466...60,372,147
Ensembl chr X:70,422,504...70,429,971
G
C
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chrNW_004955475:10,666,024...10,673,717
Ensembl chrNW_004955475:10,665,987...10,674,110
G
R
Foxo4
forkhead box O4
IEP
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:70,425,218...70,432,120
Ensembl chr X:66,385,558...66,392,115
G
M
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:100,297,855...100,304,479
Ensembl chr X:100,298,134...100,304,479
G
H
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,535
G
N
Gsr
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chrNW_004624780:13,440,269...13,497,435
Ensembl chrNW_004624780:13,440,235...13,496,535
G
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:28,778,713...28,851,907
G
P
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984
G
S
Gsr
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
G
D
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
B
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
C
Gsr
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
G
R
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24972622
RGD:10401897
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
M
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
H
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
N
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chrNW_004624747:19,843,434...20,031,188
Ensembl chrNW_004624747:19,843,720...20,029,225
G
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr11:107,403,854...107,624,534
Ensembl chr11:107,405,887...107,596,312
G
P
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr14:39,326,695...39,537,921
Ensembl chr14:39,326,792...39,536,693
G
S
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chrNW_004936668:2,390,902...2,514,653
Ensembl chrNW_004936668:2,390,405...2,514,708
G
D
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr26:9,764,437...9,954,274
Ensembl chr26:9,767,169...9,954,118
G
B
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:109,756,303...109,978,510
Ensembl chr12:113,151,017...113,311,809
G
C
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chrNW_004955482:8,714,100...8,847,975
Ensembl chrNW_004955482:8,716,092...8,847,979
G
R
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:40,800,232...40,991,584
Ensembl chr12:35,182,154...35,330,987
G
M
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr 5:121,357,323...121,506,633
Ensembl chr 5:121,358,282...121,506,640
G
H
HECTD4
HECT domain E3 ubiquitin protein ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:112,160,195...112,382,431
Ensembl chr12:112,160,188...112,382,439
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004624791:3,299,287...3,633,631
G
G
ANK3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr 9:70,549,665...71,253,928
Ensembl chr 9:70,893,260...71,254,245
G
P
ANK3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr14:63,416,154...63,809,220
Ensembl chr14:63,416,161...64,194,128
G
S
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004936614:2,664,594...2,976,174
G
D
ANK3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr 4:12,166,275...12,827,175
Ensembl chr 4:12,167,550...12,827,037
G
B
ANK3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:56,560,589...57,269,952
Ensembl chr10:58,790,696...59,602,954
G
C
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004955425:13,522,233...13,851,286
G
R
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,602,786...19,086,300
G
M
Ank3
ankyrin 3, epithelial
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
H
ANK3
ankyrin 3
IAGP
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
N
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chrNW_004624861:992,824...1,083,048
Ensembl chrNW_004624861:1,006,948...1,082,106
G
G
ARHGEF10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:1,487,076...1,620,387
Ensembl chr 8:1,502,226...1,620,389
G
P
ARHGEF10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr15:33,370,093...33,465,852
Ensembl chr15:33,370,126...33,446,598
G
S
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chrNW_004936615:1,012,009...1,103,468
Ensembl chrNW_004936615:1,048,536...1,102,242
G
D
ARHGEF10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr16:54,293,534...54,378,706
Ensembl chr16:54,293,435...54,347,555
G
B
ARHGEF10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:5,381,357...5,541,094
Ensembl chr 8:1,724,413...1,862,917
G
C
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chrNW_004955403:57,820,003...57,907,324
Ensembl chrNW_004955403:57,818,837...57,907,324
G
R
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr16:81,349,429...81,440,439
Ensembl chr16:74,647,153...74,738,173
G
M
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:14,956,405...15,051,085
Ensembl chr 8:14,961,663...15,051,085
G
H
ARHGEF10
Rho guanine nucleotide exchange factor 10
IAGP
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:1,823,300...1,958,641
Ensembl chr 8:1,823,926...1,958,641
G
N
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004624764:10,527,012...10,566,625
Ensembl chrNW_004624764:10,526,948...10,569,910
G
G
RPS6KA1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr20:106,180,708...106,226,636
Ensembl chr20:106,180,418...106,226,552
G
P
RPS6KA1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 6:83,905,124...83,947,189
Ensembl chr 6:83,905,077...83,950,963
G
S
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004936474:10,996,867...11,030,504
Ensembl chrNW_004936474:10,996,813...11,030,557
G
D
RPS6KA1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 2:73,497,128...73,533,853
Ensembl chr 2:73,497,473...73,534,378
G
B
RPS6KA1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 1:25,792,428...25,837,950
Ensembl chr 1:26,856,057...26,900,532
G
C
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004955452:5,905,561...5,938,096
Ensembl chrNW_004955452:5,904,762...5,939,091
G
R
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:146,079,021...146,118,272
G
M
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
H
RPS6KA1
ribosomal protein S6 kinase A1
IAGP
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chrNW_004624748:8,154,288...8,223,226
Ensembl chrNW_004624748:8,155,107...8,223,259
G
G
HTR2A
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr 3:24,820,029...24,884,472
Ensembl chr 3:24,820,035...24,883,432
G
P
HTR2A
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr11:20,555,939...20,620,225
Ensembl chr11:20,555,963...20,619,625
G
S
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chrNW_004936565:335,238...394,683
Ensembl chrNW_004936565:334,393...394,715
G
D
HTR2A
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr22:4,453,715...4,510,934
Ensembl chr22:4,453,715...4,511,037
G
B
HTR2A
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr13:27,976,415...28,042,941
Ensembl chr13:46,694,273...46,759,826
G
C
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
G
R
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
M
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
H
HTR2A
5-hydroxytryptamine receptor 2A
IAGP
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Arrb2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004624786:8,568,102...8,576,445
Ensembl chrNW_004624786:8,568,198...8,577,914
G
G
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr16:4,191,040...4,202,382
Ensembl chr16:4,191,172...4,202,385
G
P
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
G
S
Arrb2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004936677:3,173,054...3,181,475
Ensembl chrNW_004936677:3,172,925...3,181,520
G
D
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr 5:31,831,208...31,838,875
Ensembl chr 5:31,829,864...31,839,454
G
B
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr17:4,766,616...4,777,253
Ensembl chr17:4,757,048...4,767,517
G
C
Arrb2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004955467:10,109,985...10,118,687
Ensembl chrNW_004955467:10,110,003...10,123,022
G
R
Arrb2
arrestin, beta 2
IEP
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
M
Arrb2
arrestin, beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
H
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
G
N
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
P
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
S
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
G
D
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
B
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
C
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
G
R
Drd2
dopamine receptor D2
IEP
RGD
PMID:26174132
RGD:11534754
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
M
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
H
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
N
Gad1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chrNW_004624787:8,308,759...8,345,929
Ensembl chrNW_004624787:8,308,759...8,347,686
G
G
GAD1
glutamate decarboxylase 1
susceptibility
ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chr10:56,351,495...56,396,476
Ensembl chr10:56,353,253...56,396,524
G
P
GAD1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chr15:76,991,863...77,034,819
Ensembl chr15:76,991,928...77,034,812
G
S
Gad1
glutamate decarboxylase 1
susceptibility
ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chrNW_004936509:1,160,559...1,201,037
Ensembl chrNW_004936509:1,161,094...1,201,576
G
D
GAD1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chr36:15,351,289...15,391,701
Ensembl chr36:15,349,683...15,391,824
G
B
GAD1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chr2B:58,100,623...58,145,045
Ensembl chr2B:175,558,538...175,602,944
G
C
Gad1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chrNW_004955449:3,964,006...4,001,850
Ensembl chrNW_004955449:3,963,705...4,001,850
G
R
Gad1
glutamate decarboxylase 1
susceptibility
ISO IEP
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
M
Gad1
glutamate decarboxylase 1
susceptibility
ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
H
GAD1
glutamate decarboxylase 1
susceptibility
IAGP ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
G
N
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chrNW_004624796:2,700,443...2,771,757
Ensembl chrNW_004624796:2,703,614...2,771,555
G
G
GAD2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr 9:25,906,047...25,993,715
Ensembl chr 9:25,906,103...25,995,489
G
P
GAD2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr10:49,316,682...49,391,013
Ensembl chr10:49,313,647...49,390,926
G
S
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chrNW_004936484:1,737,806...1,810,378
Ensembl chrNW_004936484:1,737,520...1,810,398
G
D
GAD2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr 2:7,365,708...7,450,893
Ensembl chr 2:7,365,283...7,450,893
G
B
GAD2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr10:26,392,877...26,481,859
Ensembl chr10:26,759,243...26,843,197
G
C
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chrNW_004955429:3,092,977...3,170,128
Ensembl chrNW_004955429:3,096,453...3,169,259
G
R
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
M
Gad2
glutamic acid decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr 2:22,512,262...22,583,889
Ensembl chr 2:22,512,217...22,583,886
G
H
GAD2
glutamate decarboxylase 2
susceptibility
IAGP
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr10:26,216,372...26,304,558
Ensembl chr10:26,216,665...26,304,558
G
N
Oprm1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chrNW_004624785:4,147,079...4,195,712
Ensembl chrNW_004624785:4,032,689...4,196,186
G
G
OPRM1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr13:81,568,295...81,650,005
Ensembl chr13:81,568,732...81,625,088
G
P
OPRM1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 1:12,634,125...12,702,295
Ensembl chr 1:12,528,672...12,702,443
G
S
Oprm1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
G
D
OPRM1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 1:43,972,915...44,037,477
Ensembl chr 1:43,972,219...44,141,238
G
B
OPRM1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 6:151,827,323...151,937,658
Ensembl chr 6:156,517,661...157,088,251
G
C
Oprm1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chrNW_004955439:7,870,563...7,923,817
Ensembl chrNW_004955439:7,757,569...7,923,817
G
R
Oprm1
opioid receptor, mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
M
Oprm1
opioid receptor, mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
H
OPRM1
opioid receptor mu 1
IAGP
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004624791:3,299,287...3,633,631
G
G
ANK3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 9:70,549,665...71,253,928
Ensembl chr 9:70,893,260...71,254,245
G
P
ANK3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr14:63,416,154...63,809,220
Ensembl chr14:63,416,161...64,194,128
G
S
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004936614:2,664,594...2,976,174
G
D
ANK3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 4:12,166,275...12,827,175
Ensembl chr 4:12,167,550...12,827,037
G
B
ANK3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:56,560,589...57,269,952
Ensembl chr10:58,790,696...59,602,954
G
C
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004955425:13,522,233...13,851,286
G
R
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,602,786...19,086,300
G
M
Ank3
ankyrin 3, epithelial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
H
ANK3
ankyrin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
N
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chrNW_004624907:1,752,322...1,755,308
G
G
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
P
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
S
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chrNW_004936706:1,512,438...1,516,805
G
D
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
B
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
C
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
R
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
M
Apoe
apolipoprotein E
IMP
RGD
PMID:15007105
RGD:12904641
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
H
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
N
Avp
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chrNW_004624741:4,208,305...4,210,097
Ensembl chrNW_004624741:4,208,329...4,210,071
G
G
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr 2:33,761,066...33,764,608
Ensembl chr 2:33,761,140...33,763,172
G
P
AVP
vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr17:32,581,234...32,583,145
Ensembl chr17:32,581,234...32,583,185
G
D
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
G
B
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr20:3,169,094...3,172,900
G
R
Avp
arginine vasopressin
IEP
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
M
Avp
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
H
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
G
N
Bpifa1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chrNW_004624842:6,024,460...6,031,718
G
G
BPIFA1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 2:37,571,577...37,579,529
Ensembl chr 2:37,573,837...37,578,667
G
P
BPIFA1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr17:36,754,498...36,761,622
Ensembl chr17:36,754,498...36,761,621
G
D
BPIFA1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr24:22,475,407...22,482,666
Ensembl chr24:22,457,631...22,482,661
G
B
BPIFA1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:29,524,619...29,532,996
Ensembl chr20:30,642,191...30,649,515
G
C
Bpifa1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chrNW_004955422:28,063,077...28,069,939
G
R
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 3:163,087,965...163,093,708
Ensembl chr 3:142,627,810...142,633,552
G
M
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 2:153,984,800...153,991,137
Ensembl chr 2:153,984,800...153,991,139
G
H
BPIFA1
BPI fold containing family A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:33,235,996...33,243,306
Ensembl chr20:33,235,995...33,243,311
G
N
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
G
G
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 6:6,250,422...6,289,264
G
P
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
S
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chrNW_004936588:3,985,732...4,023,221
G
D
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
B
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
C
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
G
R
C3
complement C3
IEP
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
M
C3
complement component 3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
H
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
G
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr12:18,525,855...18,624,048
Ensembl chr12:18,525,880...18,623,636
G
P
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
G
S
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chrNW_004936487:9,391,774...9,474,168
Ensembl chrNW_004936487:9,391,804...9,474,159
G
D
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr11:73,953,727...74,029,919
Ensembl chr11:73,953,727...74,029,851
G
B
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
G
R
C5
complement C5
IEP
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
H
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
N
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
G
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
G
P
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
S
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
G
D
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
B
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
C
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
R
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
M
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
H
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
N
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004624849:2,484,144...2,528,130
Ensembl chrNW_004624849:2,484,109...2,528,223
G
P
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr12:17,251,361...17,306,308
Ensembl chr12:17,252,020...17,306,285
G
S
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004936541:2,288,847...2,333,129
Ensembl chrNW_004936541:2,288,841...2,331,689
G
D
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 9:9,708,696...9,763,281
Ensembl chr 9:9,714,204...9,763,402
G
B
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr17:11,261,435...11,313,630
Ensembl chr17:11,650,057...11,701,208
G
C
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004955478:10,380,185...10,390,838
Ensembl chrNW_004955478:10,379,287...10,404,825
G
R
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
IEP
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
M
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
H
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
N
Dio3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624734:2,611,864...2,613,932
G
G
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr24:79,538,264...79,544,448
G
P
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
G
S
Dio3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004936604:5,241,877...5,243,910
G
D
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 8:69,696,779...69,698,880
G
B
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr14:82,188,126...82,190,220
G
C
Dio3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004955538:1,042,949...1,045,038
G
R
Dio3
iodothyronine deiodinase 3
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660
G
M
Dio3
deiodinase, iodothyronine type III
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
G
H
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
N
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624828:2,316,042...2,358,866
Ensembl chrNW_004624828:2,315,251...2,358,711
G
G
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:9,199,006...9,263,890
Ensembl chr 6:9,199,003...9,263,607
G
P
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
S
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936659:520,181...565,496
Ensembl chrNW_004936659:520,493...565,416
G
D
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:50,872,213...50,928,352
Ensembl chr20:50,879,527...50,928,029
G
B
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:9,681,847...9,745,334
Ensembl chr19:10,342,478...10,406,972
G
C
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462
G
R
Dnmt1
DNA methyltransferase 1
IEP
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
M
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
H
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
N
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624842:6,450,972...6,505,929
Ensembl chrNW_004624842:6,450,852...6,475,785
G
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:37,128,635...37,176,033
Ensembl chr 2:37,146,538...37,174,570
G
P
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
S
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936485:19,547,836...19,570,716
G
D
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900
G
B
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:29,049,993...29,096,957
Ensembl chr20:30,186,069...30,215,487
G
C
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301
G
R
Dnmt3b
DNA methyltransferase 3 beta
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
M
Dnmt3b
DNA methyltransferase 3B
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
H
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
N
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
G
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
P
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
S
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
G
D
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 5:19,732,842...19,795,241
Ensembl chr 5:19,732,836...19,795,241
G
B
DRD2
dopamine receptor D2
ISO
mRNA:decreased expression: pituitary gland (rat) DNA:Hypermethylation:promoter
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr11:108,289,838...108,357,174
Ensembl chr11:112,132,703...112,198,935
G
C
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004955412:15,054,255...15,114,558
Ensembl chrNW_004955412:15,054,038...15,114,573
G
R
Drd2
dopamine receptor D2
IDA IEP
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
M
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
H
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
N
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624754:24,354,271...24,368,319
Ensembl chrNW_004624754:24,354,284...24,368,638
G
G
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr17:40,123,935...40,141,942
Ensembl chr17:40,124,640...40,141,616
G
P
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 7:23,977,683...23,992,673
Ensembl chr 7:23,977,683...23,992,697
G
S
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936727:1,648,451...1,663,294
Ensembl chrNW_004936727:1,648,448...1,663,455
G
D
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr12:1,341,202...1,354,602
Ensembl chr12:1,341,191...1,354,584
G
B
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:31,542,946...31,560,894
Ensembl chr 6:32,429,271...32,451,844
G
C
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955437:396,736...411,144
Ensembl chrNW_004955437:396,742...411,144
G
R
Ehmt2
euchromatic histone lysine methyltransferase 2
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547
G
M
Ehmt2
euchromatic histone lysine N-methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
G
H
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,698
G
N
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chrNW_004624896:962,253...1,173,842
Ensembl chrNW_004624896:966,487...1,173,625
G
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chr26:55,319,667...55,543,116
Ensembl chr26:55,471,907...55,538,855
G
P
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chr 1:140,566,443...140,906,516
Ensembl chr 1:140,566,540...140,905,623
G
S
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta3
sexual_dimorphism treatment
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chrNW_004936471:39,791,633...40,193,049
Ensembl chrNW_004936471:39,791,613...40,187,923
G
D
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
sexual_dimorphism treatment
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chr 3:33,878,948...34,101,987
Ensembl chr 3:33,878,904...34,097,764
G
B
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
sexual_dimorphism treatment
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chr15:3,129,481...3,357,495
Ensembl chr15:23,981,359...24,058,357
G
C
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chrNW_004955533:2,879,437...2,938,952
Ensembl chrNW_004955533:2,573,599...2,938,952
G
R
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
treatment sexual_dimorphism
IEP ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
M
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
treatment sexual_dimorphism
ISO IEP
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
H
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
N
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chrNW_004624733:27,506,827...27,593,750
Ensembl chrNW_004624733:27,504,660...27,594,039
G
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr23:64,422,519...64,512,124
Ensembl chr23:64,422,391...64,513,652
G
P
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr16:61,441,622...61,543,375
Ensembl chr16:61,441,632...61,543,361
G
S
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chrNW_004936515:1,609,370...1,670,412
Ensembl chrNW_004936515:1,607,722...1,671,336
G
D
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 4:48,794,770...48,901,859
Ensembl chr 4:48,796,852...48,901,548
G
B
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 5:157,436,113...157,529,586
Ensembl chr 5:164,068,122...164,222,179
G
C
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chrNW_004955408:15,766,161...15,857,121
Ensembl chrNW_004955408:15,765,984...15,857,244
G
R
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
IEP
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
M
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
H
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
N
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chrNW_004624752:24,008,520...24,480,834
Ensembl chrNW_004624752:24,135,487...24,459,288
G
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chr11:13,444,155...13,873,034
Ensembl chr11:13,456,968...13,873,202
G
P
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chr 5:58,477,862...58,948,735
Ensembl chr 5:58,480,528...58,927,558
G
S
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chrNW_004936587:3,406,055...3,806,956
Ensembl chrNW_004936587:3,405,698...3,804,664
G
D
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chr27:32,470,889...32,883,606
Ensembl chr27:32,471,153...32,877,680
G
B
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chr12:13,543,104...13,987,437
Ensembl chr12:13,969,387...14,388,799
G
C
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chrNW_004955413:10,358,931...10,780,004
Ensembl chrNW_004955413:10,376,597...10,779,145
G
R
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
IMP IEP
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
M
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
H
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
G
M
Hc
hemolytic complement
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
N
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624856:4,834,197...4,861,546
Ensembl chrNW_004624856:4,834,217...4,861,592
G
G
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr13:59,873,248...59,904,542
Ensembl chr13:59,873,767...59,905,742
G
P
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 1:79,867,713...79,901,597
Ensembl chr 1:79,863,094...79,901,585
G
S
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936679:2,448,676...2,474,641
Ensembl chrNW_004936679:2,448,390...2,474,641
G
D
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr12:70,053,822...70,083,491
Ensembl chr12:70,053,297...70,103,578
G
B
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:111,731,139...111,761,826
Ensembl chr 6:115,802,367...115,833,004
G
C
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955526:2,739,099...2,759,640
Ensembl chrNW_004955526:2,728,377...2,759,707
G
R
Hdac2
histone deacetylase 2
IEP
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
M
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
H
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
N
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624847:3,846,196...4,101,537
Ensembl chrNW_004624847:3,845,858...4,101,487
G
G
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr10:125,098,375...125,450,524
Ensembl chr10:125,098,366...125,403,227
G
P
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr15:138,378,237...138,657,266
Ensembl chr15:138,381,635...138,614,301
G
S
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936745:1,730,743...1,942,071
Ensembl chrNW_004936745:1,730,694...1,942,074
G
D
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr25:49,318,621...49,545,314
Ensembl chr25:49,317,349...49,453,478
G
B
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr2B:126,287,745...126,649,815
Ensembl chr2B:245,123,061...245,427,054
G
C
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955542:1,629,691...1,886,160
Ensembl chrNW_004955542:1,629,691...1,886,210
G
R
Hdac4
histone deacetylase 4
IEP
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
G
M
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
H
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:239,048,168...239,401,649 NCBI chr 2:239,193,331...239,195,457
Ensembl chr 2:239,048,168...239,401,654
G
N
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chrNW_004624746:18,883,587...18,889,205
Ensembl chrNW_004624746:18,883,353...18,889,402
G
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 5:60,017,967...60,040,959
Ensembl chr 5:60,019,434...60,025,353
G
P
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 6:28,084,087...28,089,256
Ensembl chr 6:28,083,955...28,089,671
G
S
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chrNW_004936475:17,882,663...17,888,708
Ensembl chrNW_004936475:17,882,575...17,887,748
G
D
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 5:81,966,397...81,970,301
Ensembl chr 5:81,966,937...81,968,991
G
B
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr16:47,776,118...47,782,861
Ensembl chr16:67,165,215...67,171,417
G
C
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chrNW_004955484:9,206,681...9,212,356
Ensembl chrNW_004955484:9,206,681...9,212,356
G
R
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
IEP
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
G
M
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
H
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
N
Igf1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004624750:5,881,065...5,954,799
Ensembl chrNW_004624750:5,881,091...5,952,300
G
G
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
P
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
S
Igf1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
G
D
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
B
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
C
Igf1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
R
Igf1
insulin-like growth factor 1
IEP
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
M
Igf1
insulin-like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
H
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
N
Igf1r
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004624768:5,396,027...5,688,435
Ensembl chrNW_004624768:5,396,156...5,681,809
G
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr29:17,212,206...17,534,036
Ensembl chr29:17,459,404...17,526,930
G
P
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
S
Igf1r
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
G
D
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
B
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:77,332,926...77,648,474
Ensembl chr15:96,535,164...96,832,974
G
C
Igf1r
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004955416:26,101,090...26,382,660
Ensembl chrNW_004955416:26,102,628...26,382,666
G
R
Igf1r
insulin-like growth factor 1 receptor
IEP
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
M
Igf1r
insulin-like growth factor I receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
H
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
G
LOC103243260
corticotropin-releasing factor receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr16:60,070,156...60,120,857
Ensembl chr16:60,070,066...60,120,712
G
N
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624749:17,596,381...17,603,804
Ensembl chrNW_004624749:17,596,381...17,603,867
G
G
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr14:21,609,533...21,615,822
Ensembl chr14:21,611,040...21,615,615
G
P
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 3:59,220,203...59,225,097
Ensembl chr 3:59,218,688...59,225,249
G
S
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004936712:1,710,513...1,717,339
Ensembl chrNW_004936712:1,709,716...1,717,499
G
D
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:39,525,635...39,532,512
Ensembl chr17:39,525,626...39,532,512
G
B
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr2A:85,589,301...85,595,437
Ensembl chr2A:87,141,857...87,148,322
G
C
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004955424:1,953,623...1,961,164
Ensembl chrNW_004955424:1,953,623...1,961,164
G
R
Mat2a
methionine adenosyltransferase 2A
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:104,488,466...104,495,493
G
M
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541
G
H
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
N
Mecp2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chrNW_004624946:620,581...685,339
Ensembl chrNW_004624946:628,284...685,246
G
G
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chr X:128,445,028...128,519,892
Ensembl chr X:128,453,577...128,455,785
G
P
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chr X:124,735,523...124,789,063
Ensembl chr X:124,735,656...124,738,659
G
S
Mecp2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chrNW_004936809:902,938...967,771
Ensembl chrNW_004936809:911,764...966,839
G
D
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chr X:121,866,721...121,876,088
Ensembl chr X:121,873,218...121,932,994
G
B
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chr X:143,571,864...143,647,192
Ensembl chr X:153,465,204...153,527,854
G
C
Mecp2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chrNW_004955580:674,014...737,586
Ensembl chrNW_004955580:679,109...735,288
G
R
Mecp2
methyl CpG binding protein 2
treatment
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
M
Mecp2
methyl CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
H
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
P
MIR326
microRNA mir-326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 9:9,581,944...9,582,034
Ensembl chr 9:9,581,944...9,582,034
G
D
MIR326
microRNA mir-326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr21:23,240,463...23,240,553
Ensembl chr21:23,240,463...23,240,553
G
R
Mir326
microRNA 326
IEP
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 1:163,266,165...163,266,259
Ensembl chr 1:153,854,029...153,854,123
G
M
Mir326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 7:99,201,476...99,201,570
Ensembl chr 7:99,201,476...99,201,570
G
H
MIR326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr11:75,335,092...75,335,186
Ensembl chr11:75,335,092...75,335,186
G
P
MIR7-1
microRNA mir-7-1
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 1:191,218,565...191,218,648
Ensembl chr 1:191,218,565...191,218,648
G
D
MIR7-3
microRNA mir-7-3
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr20:54,993,200...54,993,287
Ensembl chr20:54,993,200...54,993,287
G
H
MIR7-3
microRNA 7-3
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr19:4,770,670...4,770,779
Ensembl chr19:4,770,670...4,770,779
G
M
Mir7b
microRNA 7b
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr17:56,549,988...56,550,098
Ensembl chr17:56,549,988...56,550,098
G
R
Mir9
microRNA 9
IEP
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 9:1,167,436...1,167,545
Ensembl chr 9:1,080,274...1,080,383
G
N
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624775:13,791,690...13,903,888
Ensembl chrNW_004624775:13,792,043...13,896,559
G
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr25:73,935,666...74,039,872
Ensembl chr25:73,935,225...74,038,741
G
P
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr14:54,546,978...54,652,780
Ensembl chr14:54,546,978...54,652,763
G
S
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004936484:16,087,924...16,180,089
Ensembl chrNW_004936484:16,087,923...16,180,148
G
D
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 4:3,219,851...3,328,000
Ensembl chr 4:3,215,090...3,328,115
G
B
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 1:212,353,195...212,463,304
Ensembl chr 1:217,358,050...217,460,946
G
C
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004955492:3,372,915...3,474,173
Ensembl chrNW_004955492:3,376,512...3,474,180
G
R
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:58,220,071...58,304,822
G
M
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
G
H
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
G
N
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chrNW_004624747:15,940,614...16,118,051
Ensembl chrNW_004624747:16,003,969...16,113,165
G
G
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr11:112,642,374...112,673,882
G
P
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr14:35,112,898...35,299,297
Ensembl chr14:35,113,184...35,295,944
G
S
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
G
D
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr26:13,787,341...13,895,176
Ensembl chr26:13,786,309...13,962,332
G
B
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:114,784,232...114,938,385
Ensembl chr12:118,163,655...118,314,005
G
C
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chrNW_004955455:13,797,557...13,978,402
Ensembl chrNW_004955455:13,797,545...13,972,566
G
R
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
M
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
H
NOS1
nitric oxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
G
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 7:94,574,010...94,935,348
G
P
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 8:80,303,172...80,669,050
Ensembl chr 8:80,312,234...80,668,412
G
S
Nr3c2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004936535:1,139,687...1,467,469
Ensembl chrNW_004936535:1,140,178...1,467,471
G
D
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr15:46,390,030...46,718,000
Ensembl chr15:46,390,023...46,710,131
G
B
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 4:140,418,624...140,785,180
Ensembl chr 4:152,108,508...152,430,298
G
C
Nr3c2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004955471:3,059,210...3,397,894
Ensembl chrNW_004955471:3,061,735...3,395,520
G
R
Nr3c2
nuclear receptor subfamily 3, group C, member 2
sexual_dimorphism
IEP
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
M
Nr3c2
nuclear receptor subfamily 3, group C, member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
H
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
N
Oprk1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624735:2,301,248...2,325,678
Ensembl chrNW_004624735:2,301,101...2,325,684
G
G
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:49,337,308...49,364,724
Ensembl chr 8:49,341,427...49,362,947
G
P
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 4:77,399,298...77,429,025
Ensembl chr 4:77,399,183...77,426,879
G
S
Oprk1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004936496:280,593...305,900
Ensembl chrNW_004936496:280,558...305,904
G
D
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr29:5,022,270...5,054,223
Ensembl chr29:5,025,786...5,051,919
G
B
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:49,650,844...49,677,494
Ensembl chr 8:47,029,313...47,056,577
G
C
Oprk1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004955454:12,741,577...12,751,282
Ensembl chrNW_004955454:12,744,765...12,752,226
G
R
Oprk1
opioid receptor, kappa 1
IEP
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
M
Oprk1
opioid receptor, kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
H
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
N
Oprl1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624741:29,713,937...29,720,617
Ensembl chrNW_004624741:29,714,477...29,720,716
G
P
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr17:62,905,700...62,913,018
Ensembl chr17:62,905,082...62,913,754
G
S
Oprl1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004936514:11,264,392...11,273,584
Ensembl chrNW_004936514:11,258,335...11,273,592
G
D
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr24:47,530,039...47,537,477
Ensembl chr24:47,508,136...47,537,250
G
B
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
Ensembl chr20:62,004,176...62,017,866
G
C
Oprl1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004955528:161,673...184,515
Ensembl chrNW_004955528:161,673...167,937
G
R
Oprl1
opioid related nociceptin receptor 1
IEP
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
M
Oprl1
opioid receptor-like 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
H
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
N
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624741:3,239,101...3,253,507
Ensembl chrNW_004624741:3,237,942...3,253,503
G
G
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:54,535,516...54,551,085
Ensembl chr 2:54,535,240...54,551,104
G
P
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
G
S
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004936485:16,559,371...16,571,461
Ensembl chrNW_004936485:16,559,217...16,571,678
G
D
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr24:19,043,955...19,057,413
Ensembl chr24:19,053,870...19,056,364
G
B
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr20:2,092,171...2,108,141
Ensembl chr20:1,856,850...1,872,452
G
C
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004955415:13,106,087...13,119,497
Ensembl chrNW_004955415:13,106,062...13,119,515
G
R
Pdyn
prodynorphin
IEP
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
M
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
H
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
N
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004624847:3,359,174...3,399,584
Ensembl chrNW_004624847:3,361,170...3,390,405
G
G
PER2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr10:124,270,917...124,316,031
Ensembl chr10:124,269,543...124,315,904
G
P
PER2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr15:137,793,419...137,837,854
Ensembl chr15:137,793,422...137,837,070
G
S
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004936525:221,601...263,284
Ensembl chrNW_004936525:221,510...263,295
G
D
PER2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr25:48,716,499...48,761,617
Ensembl chr25:48,717,173...48,758,755
G
B
PER2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr2B:125,477,021...125,521,577
Ensembl chr2B:244,328,122...244,371,040
G
C
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004955542:2,331,547...2,369,011
Ensembl chrNW_004955542:2,338,099...2,371,274
G
R
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
M
Per2
period circadian clock 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
H
PER2
period circadian regulator 2
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
N
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624758:23,007,530...23,026,962
Ensembl chrNW_004624758:23,007,573...23,028,704
G
G
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:26,418,473...26,444,689
Ensembl chr 8:26,418,815...26,444,677
G
P
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr14:12,101,223...12,134,174
Ensembl chr14:12,101,698...12,133,778
G
S
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004936675:1,113,435...1,134,916
Ensembl chrNW_004936675:1,113,435...1,134,910
G
D
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr25:29,223,758...29,246,487
Ensembl chr25:29,224,092...29,245,851
G
B
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:27,596,413...27,622,844
Ensembl chr 8:24,796,638...24,822,758
G
C
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004955403:50,735,567...50,755,892
Ensembl chrNW_004955403:50,735,390...50,755,902
G
R
Pnoc
prepronociceptin
IEP
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
M
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr14:65,638,931...65,662,908
Ensembl chr14:65,638,122...65,662,921
G
H
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:28,316,988...28,343,351
Ensembl chr 8:28,316,986...28,343,355
G
N
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004624738:7,442,223...7,448,513
Ensembl chrNW_004624738:7,442,292...7,445,020
G
G
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr14:82,491,296...82,499,289
Ensembl chr14:82,494,323...82,499,447
G
P
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
G
S
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
G
D
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
B
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
G
C
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
R
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
M
Pomc
pro-opiomelanocortin-alpha
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
H
POMC
proopiomelanocortin
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
N
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004624756:4,585,542...4,593,285
G
G
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr17:49,922,750...49,938,084
Ensembl chr17:49,928,321...49,938,631
G
P
PRL
prolactin
ISO
mRNA, protein:increased expression:pituitary gland, blood plasma (rat) mRNA,protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
S
Prl
prolactin
ISO
mRNA, protein:increased expression:pituitary gland, blood plasma (rat) mRNA,protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004936552:7,204,298...7,212,632
G
D
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr35:20,673,830...20,683,824
Ensembl chr35:20,673,839...20,683,824
G
B
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chr 6:22,109,974...22,125,433
Ensembl chr 6:22,450,132...22,459,829
G
C
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004955483:4,495,257...4,503,377
G
R
Prl
prolactin
IEP
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
M
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
H
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
N
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chrNW_004624791:13,975,235...14,056,900
G
G
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
G
P
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr14:99,929,590...100,021,619
G
S
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
G
D
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176
G
B
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
G
C
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
G
R
Pten
phosphatase and tensin homolog
IEP
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
M
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
H
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
N
Rasgrf1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624941:110,752...222,143
Ensembl chrNW_004624941:110,676...222,092
G
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr26:4,298,091...4,431,606
Ensembl chr26:4,299,116...4,432,420
G
P
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 7:48,121,415...48,246,749
Ensembl chr 7:48,121,419...48,246,749
G
S
Rasgrf1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004936471:37,173,595...37,278,356
Ensembl chrNW_004936471:37,171,297...37,278,529
G
D
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 3:57,995,092...58,085,395
Ensembl chr 3:57,995,786...58,085,380
G
B
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:57,933,152...58,063,824
Ensembl chr15:76,891,556...77,022,534
G
C
Rasgrf1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004955533:69,736...167,626
Ensembl chrNW_004955533:70,897...167,460
G
R
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:90,445,154...90,574,269
G
M
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
G
H
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
G
N
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004624764:10,527,012...10,566,625
Ensembl chrNW_004624764:10,526,948...10,569,910
G
G
RPS6KA1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr20:106,180,708...106,226,636
Ensembl chr20:106,180,418...106,226,552
G
P
RPS6KA1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 6:83,905,124...83,947,189
Ensembl chr 6:83,905,077...83,950,963
G
S
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004936474:10,996,867...11,030,504
Ensembl chrNW_004936474:10,996,813...11,030,557
G
D
RPS6KA1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 2:73,497,128...73,533,853
Ensembl chr 2:73,497,473...73,534,378
G
B
RPS6KA1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:25,792,428...25,837,950
Ensembl chr 1:26,856,057...26,900,532
G
C
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004955452:5,905,561...5,938,096
Ensembl chrNW_004955452:5,904,762...5,939,091
G
R
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:146,079,021...146,118,272
G
M
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
H
RPS6KA1
ribosomal protein S6 kinase A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
N
Setd7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624777:19,764,383...19,812,804
Ensembl chrNW_004624777:19,768,698...19,814,506
G
G
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 7:86,476,101...86,528,146
Ensembl chr 7:86,481,726...86,527,779
G
P
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 8:87,478,266...87,527,190
Ensembl chr 8:87,478,173...87,527,188
G
S
Setd7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004936535:8,094,479...8,143,108
Ensembl chrNW_004936535:8,094,178...8,137,580
G
D
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:3,186,620...3,229,305
Ensembl chr19:3,186,906...3,224,113
G
B
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 4:131,869,999...131,921,342
Ensembl chr 4:143,167,190...143,227,732
G
C
Setd7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004955428:4,131,431...4,178,250
Ensembl chrNW_004955428:4,131,103...4,178,250
G
R
Setd7
SET domain containing 7, histone lysine methyltransferase
IEP
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:137,713,545...137,756,319
Ensembl chr 2:135,562,683...135,605,468
G
M
Setd7
SET domain containing (lysine methyltransferase) 7
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 3:51,422,740...51,468,519
Ensembl chr 3:51,422,740...51,468,300
G
H
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 4:139,492,974...139,556,219
Ensembl chr 4:139,495,941...139,606,699
G
N
Slc25a12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624787:9,187,450...9,319,684
Ensembl chrNW_004624787:9,184,514...9,320,060
G
G
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr10:57,268,948...57,387,958
Ensembl chr10:57,265,550...57,387,910
G
P
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:77,895,935...78,021,930
Ensembl chr15:77,895,938...78,098,383
G
S
Slc25a12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004936509:1,994,082...2,077,731
Ensembl chrNW_004936509:1,990,116...2,077,938
G
D
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr36:16,185,011...16,391,080
Ensembl chr36:16,185,649...16,483,016
G
B
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr2B:59,071,123...59,297,327
Ensembl chr2B:176,532,940...176,641,894
G
C
Slc25a12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004955449:3,093,603...3,182,513
Ensembl chrNW_004955449:3,093,603...3,186,737
G
R
Slc25a12
solute carrier family 25 member 12
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:56,097,269...56,192,100
G
M
Slc25a12
solute carrier family 25 (mitochondrial carrier, Aralar), member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
G
H
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
N
Slc6a4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624786:2,673,285...2,711,432
Ensembl chrNW_004624786:2,672,552...2,710,914
G
G
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr16:23,929,196...23,969,665
Ensembl chr16:23,927,311...23,955,616
G
P
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr12:46,285,995...46,328,377
Ensembl chr12:46,285,997...46,314,378
G
S
Slc6a4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004936538:6,205,268...6,239,062
Ensembl chrNW_004936538:6,205,251...6,239,083
G
D
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 9:44,224,026...44,259,655
Ensembl chr 9:44,224,229...44,259,736
G
B
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:26,546,177...26,572,301
Ensembl chr17:27,050,900...27,092,882
G
C
Slc6a4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004955481:3,088,440...3,122,421
Ensembl chrNW_004955481:3,088,416...3,125,711
G
R
Slc6a4
solute carrier family 6 member 4
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
M
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
H
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
N
Tlr4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
G
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
P
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
S
Tlr4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
D
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
B
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
C
Tlr4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
R
Tlr4
toll-like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
M
Tlr4
toll-like receptor 4
ameliorates
IMP
RGD
PMID:30312858
RGD:405866345
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
H
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
G
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr26:56,638,936...56,738,555
Ensembl chr26:56,666,162...56,736,737
G
P
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 1:141,887,179...142,001,595
Ensembl chr 1:141,887,227...141,995,003
G
S
Ube3a
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004936471:41,187,665...41,290,345
Ensembl chrNW_004936471:41,187,612...41,283,517
G
D
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 3:35,347,034...35,442,329
Ensembl chr 3:35,347,064...35,440,256
G
B
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:4,494,029...4,595,415
Ensembl chr15:22,747,075...22,825,459
G
C
Ube3a
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004955533:3,733,148...3,828,353
Ensembl chrNW_004955533:3,733,148...3,821,577
G
R
Ube3a
ubiquitin protein ligase E3A
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:110,070,480...110,157,250
G
M
Ube3a
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 7:58,871,891...58,960,585
Ensembl chr 7:58,878,498...58,961,284
G
H
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:25,333,728...25,439,056
Ensembl chr15:25,333,728...25,439,051
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chrNW_004624730:3,316,122...3,361,820
G
G
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr22:10,757,381...10,809,257
Ensembl chr22:10,757,337...10,772,704
G
P
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
S
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
G
D
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
G
B
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,282,009...49,339,887
G
C
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chrNW_004955532:1,300,821...1,347,453
Ensembl chrNW_004955532:1,300,462...1,347,451
G
R
Rhoa
ras homolog family member A
IEP
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
M
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
H
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Ager
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004624754:24,138,086...24,140,900
G
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
G
P
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
S
Ager
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
G
D
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
B
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
C
Ager
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
G
R
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
M
Ager
advanced glycosylation end product-specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
H
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
N
Agtr1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chrNW_004624730:25,964,848...26,006,468
Ensembl chrNW_004624730:25,964,811...26,006,463
G
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr15:41,957,826...42,002,776
G
P
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105
G
S
Agtr1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chrNW_004936519:6,831,096...6,873,977
Ensembl chrNW_004936519:6,831,096...6,873,985
G
D
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
G
B
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:145,722,475...145,767,550
Ensembl chr 3:153,341,947...153,345,380
G
C
Agtr1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chrNW_004955474:8,733,942...8,781,305
Ensembl chrNW_004955474:8,733,942...8,781,255
G
H
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
R
Agtr1a
angiotensin II receptor, type 1a
IEP
RGD
PMID:24814703
RGD:10047100
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
M
Agtr1a
angiotensin II receptor, type 1a
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
R
Agtr1b
angiotensin II receptor, type 1b
IEP
RGD
PMID:24814703
RGD:10047100
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:102,844,969...102,920,232
G
M
Agtr1b
angiotensin II receptor, type 1b
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:20,368,637...20,421,341
Ensembl chr 3:20,368,637...20,421,341
G
N
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
G
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
P
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
G
S
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
G
D
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
B
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
C
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
R
Akt1
AKT serine/threonine kinase 1
treatment
IEP
RGD
PMID:30221701
RGD:597931096
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
M
Akt1
thymoma viral proto-oncogene 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
H
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
N
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chrNW_004624745:13,904,912...14,159,374
Ensembl chrNW_004624745:13,902,577...14,159,372
G
G
APP
amyloid beta precursor protein
treatment
ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chr 2:66,037,224...66,320,860
Ensembl chr 2:66,037,261...66,321,306
G
P
APP
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
S
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chrNW_004936640:1,549,977...1,787,436
Ensembl chrNW_004936640:1,550,167...1,787,286
G
D
APP
amyloid beta precursor protein
treatment
ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
G
B
APP
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chr21:12,324,455...12,608,594
Ensembl chr21:25,684,355...25,995,072
G
C
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chrNW_004955407:25,725,259...25,973,582
Ensembl chrNW_004955407:25,722,849...25,974,268
G
R
App
amyloid beta precursor protein
treatment
IEP ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597931096 , RGD:597830178 , RGD:597830151
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
M
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597931096 , RGD:597830178 , RGD:597830151
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
H
APP
amyloid beta precursor protein
treatment
ISO IEP
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597931096 , RGD:597830178 , RGD:597830151
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
N
Bace1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004624784:12,725,419...12,759,530
Ensembl chrNW_004624784:12,725,063...12,759,637
G
G
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 1:108,659,723...108,689,879
Ensembl chr 1:108,657,584...108,689,843
G
P
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 9:44,640,389...44,665,863
Ensembl chr 9:44,640,394...44,665,835
G
S
Bace1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004936542:2,514,297...2,539,088
Ensembl chrNW_004936542:2,514,300...2,539,135
G
D
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 5:16,308,953...16,319,100
Ensembl chr 5:16,308,944...16,319,100
G
B
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr11:112,120,950...112,151,505
Ensembl chr11:116,054,303...116,084,812
G
C
Bace1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004955412:18,596,643...18,620,089
Ensembl chrNW_004955412:18,596,643...18,620,362
G
R
Bace1
beta-secretase 1
treatment
IEP IMP
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
M
Bace1
beta-site APP cleaving enzyme 1
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
H
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
G
N
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004624832:5,050,222...5,068,565
Ensembl chrNW_004624832:5,050,222...5,055,506
G
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 6:42,186,028...42,193,105
G
P
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
G
S
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
G
D
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
B
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
C
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
G
R
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
M
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
H
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
N
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
G
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
P
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
S
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
G
D
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
B
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
C
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
G
R
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:33574912
RGD:597830178
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
M
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
H
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
N
Bdnf
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004624766:17,281,882...17,330,601
Ensembl chrNW_004624766:17,279,630...17,330,490
G
G
BDNF
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
P
BDNF
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
S
Bdnf
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
G
D
BDNF
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
B
BDNF
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
C
Bdnf
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
G
R
Bdnf
brain-derived neurotrophic factor
treatment
IEP ISO
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
M
Bdnf
brain derived neurotrophic factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
H
BDNF
brain derived neurotrophic factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
P
CASP3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
S
Casp3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004936554:4,571,072...4,593,765
G
D
CASP3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
B
CASP3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
C
Casp3
caspase 3
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004955403:24,315,712...24,326,271
G
R
Casp3
caspase 3
treatment
IEP
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
M
Casp3
caspase 3
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
H
CASP3
caspase 3
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
N
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chrNW_004624765:8,374,160...8,436,969
G
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chr10:93,316,774...93,395,187
Ensembl chr10:93,316,840...93,388,832
G
P
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chr15:110,705,548...110,773,037
Ensembl chr15:110,705,496...110,771,728
G
S
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chrNW_004936631:3,721,307...3,785,346
Ensembl chrNW_004936631:3,721,313...3,780,892
G
D
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chr37:15,921,214...15,978,492
Ensembl chr37:15,939,138...15,977,556
G
B
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chr2B:94,762,796...94,836,304
Ensembl chr2B:212,891,261...212,958,130
G
C
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chrNW_004955457:7,424,403...7,490,630
Ensembl chrNW_004955457:7,431,736...7,491,149
G
R
Creb1
cAMP responsive element binding protein 1
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
M
Creb1
cAMP responsive element binding protein 1
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
H
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
N
Gdnf
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chrNW_004624759:17,263,570...17,290,046
Ensembl chrNW_004624759:17,263,969...17,287,723
G
G
GDNF
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chr 4:36,662,033...36,691,761
Ensembl chr 4:36,665,009...36,684,257
G
P
GDNF
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chr16:22,936,602...22,965,929
Ensembl chr16:22,936,604...22,966,536
G
S
Gdnf
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chrNW_004936518:4,291,391...4,310,752
Ensembl chrNW_004936518:4,288,154...4,310,753
G
D
GDNF
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chr 4:70,966,694...70,991,860
Ensembl chr 4:70,971,432...70,989,714
G
B
GDNF
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chr 5:72,539,374...72,566,918
Ensembl chr 5:77,577,313...77,601,362
G
C
Gdnf
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chrNW_004955426:22,386,613...22,412,324
Ensembl chrNW_004955426:22,386,450...22,412,324
G
R
Gdnf
glial cell derived neurotrophic factor
treatment
IEP ISO IDA
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
M
Gdnf
glial cell line derived neurotrophic factor
treatment
ISO IEP
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
H
GDNF
glial cell derived neurotrophic factor
treatment
ISO IEP
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
N
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004624776:7,858,400...7,862,716
Ensembl chrNW_004624776:7,793,259...7,863,184
G
G
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 3:9,353,333...9,357,765
G
P
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr11:7,195,556...7,321,071
G
S
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
G
D
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
B
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr13:11,737,942...11,894,923
Ensembl chr13:30,174,899...30,179,527
G
C
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004955431:15,373,207...15,377,339
Ensembl chrNW_004955431:15,373,207...15,377,339
G
R
Hmgb1
high mobility group box 1
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
M
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
H
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
N
Igf1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chrNW_004624750:5,881,065...5,954,799
Ensembl chrNW_004624750:5,881,091...5,952,300
G
G
IGF1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
P
IGF1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
S
Igf1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
G
D
IGF1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
B
IGF1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
C
Igf1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
R
Igf1
insulin-like growth factor 1
treatment
IEP IMP ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597830178 , RGD:597830151
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
M
Igf1
insulin-like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597830178 , RGD:597830151
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
H
IGF1
insulin like growth factor 1
treatment
ISO IEP
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597830178 , RGD:597830151
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
N
Igfbp7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chrNW_004624761:12,318,571...12,387,489
Ensembl chrNW_004624761:12,318,006...12,387,582
G
G
IGFBP7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 7:11,617,096...11,694,530
G
P
IGFBP7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 8:56,283,089...56,357,822
Ensembl chr 8:56,279,895...56,357,822
G
S
Igfbp7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chrNW_004936482:19,119,339...19,186,679
Ensembl chrNW_004936482:19,118,321...19,186,685
G
D
IGFBP7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr13:49,138,406...49,207,235
Ensembl chr13:49,138,402...49,207,394
G
B
IGFBP7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 4:66,808,845...66,888,301
Ensembl chr 4:73,382,745...73,462,087
G
C
Igfbp7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chrNW_004955447:14,048,834...14,110,264
Ensembl chrNW_004955447:14,047,732...14,108,414
G
R
Igfbp7
insulin-like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:30,737,164...30,797,314
G
M
Igfbp7
insulin-like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888
G
H
IGFBP7
insulin like growth factor binding protein 7
IEP
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 4:57,030,773...57,110,385
Ensembl chr 4:57,030,773...57,110,385
G
N
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
G
G
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
S
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
D
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
B
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
C
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
R
Il1b
interleukin 1 beta
treatment
IDA IEP
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:30221701 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597931096 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
M
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:30221701 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597931096 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
H
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:30221701 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597931096 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
N
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
G
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
P
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
G
S
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
G
D
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
B
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
C
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
R
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
M
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
H
IL1RN
interleukin 1 receptor antagonist
treatment
IDA
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
N
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
G
G
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
P
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
S
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chrNW_004936549:7,015,595...7,016,246
G
D
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
B
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chr 7:23,415,922...23,420,767
G
C
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chrNW_004955410:25,079,835...25,084,390
G
R
Il6
interleukin 6
treatment
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:30221701 PMID:28684969
RGD:401965467 , RGD:597931096 , RGD:597538492
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
M
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:30221701 PMID:28684969
RGD:401965467 , RGD:597931096 , RGD:597538492
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
H
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:30221701 PMID:28684969
RGD:401965467 , RGD:597931096 , RGD:597538492
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
N
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chrNW_004624894:2,446,014...2,498,650
Ensembl chrNW_004624894:2,445,704...2,499,009
G
G
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr26:4,842,328...4,905,941
Ensembl chr26:4,842,122...4,905,964
G
P
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 7:47,481,539...47,529,199
Ensembl chr 7:47,478,706...47,529,242
G
S
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chrNW_004936471:36,547,552...36,601,327
Ensembl chrNW_004936471:36,547,500...36,600,636
G
D
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr13:38,398,445...38,441,128
Ensembl chr13:38,400,591...38,441,015
G
B
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr15:57,367,314...57,430,322
Ensembl chr15:76,331,610...76,394,476
G
C
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chrNW_004955450:852,554...898,908
Ensembl chrNW_004955450:852,554...900,011
G
R
Ireb2
iron responsive element binding protein 2
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:55,228,085...55,311,611
G
M
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 9:54,769,942...54,819,812
Ensembl chr 9:54,771,073...54,819,814
G
H
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453
G
P
LOC110258578
interleukin-1 beta-like
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
G
N
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004624747:1,296,062...1,389,674
Ensembl chrNW_004624747:1,296,221...1,389,757
G
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr19:4,246,144...4,352,648
Ensembl chr19:4,246,122...4,353,325
G
P
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
S
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004936619:1,889,841...1,932,646
Ensembl chrNW_004936619:1,889,708...1,932,646
G
D
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
B
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr22:3,883,119...3,990,368
Ensembl chr22:20,365,487...20,450,335
G
C
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
G
R
Mapk1
mitogen activated protein kinase 1
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
M
Mapk1
mitogen-activated protein kinase 1
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
H
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
N
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004624782:13,150,824...13,158,327
Ensembl chrNW_004624782:13,152,039...13,159,113
G
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr 5:26,536,471...26,545,666
Ensembl chr 5:26,536,532...26,546,461
G
P
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
S
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004936501:12,342,670...12,390,650
Ensembl chrNW_004936501:12,384,804...12,392,180
G
D
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
B
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
Ensembl chr16:30,489,362...30,498,017
G
C
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152
G
R
Mapk3
mitogen activated protein kinase 3
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
M
Mapk3
mitogen-activated protein kinase 3
treatment
ISO IDA
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
H
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
M
Mir320
microRNA 320
treatment
ISO
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
R
Mir320a
microRNA 320a
treatment
IMP ISO
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
H
MIR320A
microRNA 320a
treatment
ISO IEP
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
N
Ngf
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chrNW_004624772:11,009,765...11,070,050
Ensembl chrNW_004624772:11,010,845...11,070,017
G
G
NGF
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chr20:18,361,795...18,413,987
Ensembl chr20:18,413,108...18,413,833
G
P
NGF
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,749...105,307,837
G
S
Ngf
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
G
D
NGF
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
B
NGF
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chr 1:87,223,597...87,276,759
G
C
Ngf
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
G
R
Ngf
nerve growth factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
M
Ngf
nerve growth factor
treatment
IEP ISO
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
H
NGF
nerve growth factor
treatment
ISO IEP IDA
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
N
Nr3c1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chrNW_004624774:2,496,276...2,603,894
Ensembl chrNW_004624774:2,495,304...2,602,632
G
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
G
P
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
S
Nr3c1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
G
D
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
G
B
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
G
C
Nr3c1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chrNW_004955415:10,494,704...10,585,778
Ensembl chrNW_004955415:10,494,640...10,586,221
G
R
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IDA IEP
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
M
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
H
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
G
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
RGD
PMID:33390808
RGD:401965467
NCBI chr 7:94,574,010...94,935,348
G
P
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
RGD
PMID:33390808
RGD:401965467
NCBI chr 8:80,303,172...80,669,050
Ensembl chr 8:80,312,234...80,668,412
G
S
Nr3c2
nuclear receptor subfamily 3 group C member 2
ISO
RGD
PMID:33390808
RGD:401965467
NCBI chrNW_004936535:1,139,687...1,467,469
Ensembl chrNW_004936535:1,140,178...1,467,471
G
D
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr15:46,390,030...46,718,000
Ensembl chr15:46,390,023...46,710,131
G
B
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 4:140,418,624...140,785,180
Ensembl chr 4:152,108,508...152,430,298
G
C
Nr3c2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chrNW_004955471:3,059,210...3,397,894
Ensembl chrNW_004955471:3,061,735...3,395,520
G
R
Nr3c2
nuclear receptor subfamily 3, group C, member 2
IEP IMP
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:33390808
RGD:401965467 , RGD:401965467
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
M
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
H
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
N
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004624809:8,274,736...8,622,287
Ensembl chrNW_004624809:8,276,951...8,616,765
G
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
P
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr10:30,030,050...30,429,938
Ensembl chr10:30,033,405...30,429,882
G
S
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004936680:267,850...621,467
Ensembl chrNW_004936680:267,596...615,928
G
D
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
B
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chr 9:39,663,986...40,208,770
Ensembl chr 9:84,021,837...84,372,678
G
C
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004955432:2,284,283...2,629,631
Ensembl chrNW_004955432:2,288,898...2,630,878
G
R
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IEP ISO
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
M
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
treatment
ISO IEP IMP
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
H
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
N
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004624730:15,226,786...15,399,097
Ensembl chrNW_004624730:15,226,379...15,355,857
G
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr15:51,705,585...51,885,848
Ensembl chr15:51,775,733...51,889,238
G
P
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr13:79,427,033...79,610,840
Ensembl chr13:79,425,835...79,610,840
G
S
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004936540:907,118...1,041,814
Ensembl chrNW_004936540:907,112...1,041,848
G
D
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr23:34,832,661...34,955,410
Ensembl chr23:34,836,540...34,993,939
G
B
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 3:135,685,120...135,867,096
Ensembl chr 3:143,288,563...143,431,314
G
C
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004955501:251,829...381,255
Ensembl chrNW_004955501:259,645...379,909
G
R
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
treatment
IEP
RGD
PMID:30221701
RGD:597931096
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:99,594,644...99,699,663
G
M
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
G
H
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928
G
N
Tlr2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
G
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
P
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
S
Tlr2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
D
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
B
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
C
Tlr2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
G
R
Tlr2
toll-like receptor 2
treatment
IEP
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
M
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
H
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
N
Tlr4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
G
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
P
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
S
Tlr4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
D
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
B
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
C
Tlr4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
R
Tlr4
toll-like receptor 4
treatment
IEP
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
M
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
H
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
N
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:hippocampus (rat) mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
G
P
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
S
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
D
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
B
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
C
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
R
Tnf
tumor necrosis factor
treatment
IEP
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
M
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
H
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Ache
acetylcholinesterase (Cartwright blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chrNW_004624740:16,275,108...16,280,639
Ensembl chrNW_004624740:16,275,117...16,281,793
G
G
ACHE
acetylcholinesterase (Cartwright blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
G
P
ACHE
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
S
Ache
acetylcholinesterase (Cartwright blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
G
D
ACHE
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
B
ACHE
acetylcholinesterase (Yt blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 7:92,915,065...92,922,079
Ensembl chr 7:106,311,944...106,318,184
G
C
Ache
acetylcholinesterase (Cartwright blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chrNW_004955573:79,606...85,799
Ensembl chrNW_004955573:80,298...85,799
G
R
Ache
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
M
Ache
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
H
ACHE
acetylcholinesterase (Yt blood group)
disease_progression
IDA
RGD
PMID:8043620
RGD:405855847
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
N
Htr1a
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chrNW_004624815:5,817,196...5,821,197
Ensembl chrNW_004624815:5,816,601...5,820,864
G
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 4:60,159,542...60,162,947
Ensembl chr 4:60,159,944...60,161,212
G
P
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr16:42,479,812...42,484,365
Ensembl chr16:42,478,923...42,484,304
G
S
Htr1a
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chrNW_004936480:5,042,531...5,047,157
Ensembl chrNW_004936480:5,043,204...5,044,472
G
D
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 2:50,005,277...50,006,548
Ensembl chr 2:50,002,740...50,006,548
G
B
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 5:50,045,266...50,049,636
Ensembl chr 5:51,692,416...51,693,684
G
C
Htr1a
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chrNW_004955446:4,913,181...4,917,726
Ensembl chrNW_004955446:4,913,884...4,915,146
G
R
Htr1a
5-hydroxytryptamine receptor 1A
IEP
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
M
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
H
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
N
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chrNW_004624750:25,702,597...25,801,938
Ensembl chrNW_004624750:25,702,630...25,801,618
G
G
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr11:67,568,744...67,664,911
G
P
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr 5:35,917,159...36,016,981
Ensembl chr 5:35,918,370...36,017,509
G
S
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chrNW_004936568:974,575...1,065,800
Ensembl chrNW_004936568:974,767...1,065,804
G
D
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr10:13,442,611...13,526,537
Ensembl chr10:13,442,611...13,527,243
G
B
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr12:69,460,883...69,557,329
Ensembl chr12:72,318,908...72,412,557
G
C
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chrNW_004955405:11,877,474...11,981,035
Ensembl chrNW_004955405:11,886,206...11,982,550
G
R
Tph2
tryptophan hydroxylase 2
IEP
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
M
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr10:114,914,546...115,020,927
Ensembl chr10:114,914,546...115,020,927
G
H
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr12:71,938,845...72,032,440
Ensembl chr12:71,938,845...72,186,618
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all